Brokerage firms remain divided on Zydus Lifesciences as the company announced to acquire France-based Amplitude Surgical for ...
The Treasury Stock Method provides valuable insights for investors by illustrating the potential dilution effect on a company’s EPS. This method is particularly useful for assessing the ...
Nuvama is of the view that the Zydus Life's latest deal would be dilutive to the company's Earnings Per Share (EPS) by 1% to ...
1,808 ($207/ $0.1145), which is about 13% higher than without the inclusion of dilutive shares. To put this huge P/E ratio of 1,592 into perspective, EPS would need to grow by 115% CAGR to get a P ...
Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...
12d
Boston Scientific will acquire SoniVie for up to $600 million on 100% basis, adding the TIVUS ultrasound system to its hypertension treatment pipeline. Deal closes in H1 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback